CDEK
← All organizations

Checkmate Pharmaceuticals

For profitWebsite ↗

Also known as: Checkmate Pharmaceuticals

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Mar 1, 2016

Last known activity

Jan 31, 2022

Acquired by Regeneron on Apr 19, 2022

Timeline

2010s

  1. Jun 1, 2015

    Checkmate Pharmaceuticals— Founded

2020s

  1. Apr 19, 2022

    Regeneron— Acquired By

Drugs by trial phase (7 distinct, 9 trials)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (9)

Details

Founded
Cambridge, MA, US Jun 1, 2015
Last known activity
Jan 31, 2022